Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1475-1480

  Hernberg, Micaela M ^a   Kivioja, Aarne H ^a   Böhling, Tom O ^b   Janes, Rita J ^a   Wiklund, Tom A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Hyperfractionated; Inoperable; Local control; Outcome

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTINUOUS INFUSION; DISEASE FREE INTERVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OSTEOSARCOMA; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84655165065     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9592-2     Document Type: Article

References (16)

1. G Bacci 2001 Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol Eur J Cancer 37 16 2030 2039
2. S Smeland 2003 Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders Eur J Cancer 39 4 488 494
3. OP Solheim G Saeter I Elomaa TA Alvegard 1992 The treatment of osteosarcoma: present trends. The Scandinavian Sarcoma Group experience Ann Oncol 3 Suppl 2 S7 S11
4. L Kager 2003 Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols J Clin Oncol 21 10 2011 2018
5. T Ozaki 2003 Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group J Clin Oncol 21 2 334 341
6. P Hundsdoerfer 2009 Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma Eur J Cancer 45 14 2447 2451
7. GN Machak 2003 Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities Mayo Clin Proc 78 2 147 155
8. TF DeLaney 2005 Radiotherapy for local control of osteosarcoma Int J Radiat Oncol Biol Phys 61 2 492 498
9. TD Wagner 2009 Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone Int J Radiat Oncol Biol Phys 73 1 259 266
10. G Bacci 2003 Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide Ann Oncol 14 7 1126 1134
11. N Jaffe 2002 Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Cancer 95 10 2202 2210
12. MV Williams J Denekamp JF Fowler 1985 A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation Int J Radiat Oncol Biol Phys 11 1 87 96
13. I Elomaa 2000 Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol Eur J Cancer 36 7 875 880
14. TW Bolek 1996 Local control and functional results after twice-daily radiotherapy for Ewing's sarcoma of the extremities Int J Radiat Oncol Biol Phys 35 4 687 692
15. C Le Pechoux 1999 Postoperative radiotherapy in the management of adult soft tissue sarcoma of the extremities: results with two different total dose, fractionation, and overall treatment time schedules Int J Radiat Oncol Biol Phys 44 4 879 886
16. A Mahajan 2008 Multimodality treatment of osteosarcoma: radiation in a high-risk cohort Pediatr Blood Cancer 50 5 976 982